62.7
Chemomab Therapeutics Ltd.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
41.7
FY23:
20.9
FY24:
16.0
FY25:
13.4
(positive)
Change from FY21 to FY25
millions USD
FY21:
1.67
FY22:
1.33
FY23:
1.25
FY24:
0.92
FY25:
0.39
Total assets
Change from FY21 to FY25
millions USD
FY21:
64.4
FY22:
43.1
FY23:
22.2
FY24:
17.0
FY25:
13.8
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
2.65
FY22:
6.75
FY23:
4.84
FY24:
3.22
FY25:
1.48
(negative)
Change from FY21 to FY25
millions USD
FY21:
0.24
FY22:
0.09
FY23:
0.32
FY24:
0.21
FY25:
0
(positive)
Change from FY21 to FY25
millions USD
FY21:
61.5
FY22:
36.2
FY23:
17.0
FY24:
13.5
FY25:
12.3
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
64.4
FY22:
43.1
FY23:
22.2
FY24:
17.0
FY25:
13.8
All amounts in millions USD